Introduction
Silver is a toxic heavy metal and is often found associated with environmental contamination with other toxic heavy metals such as lead and mercury. However, driven by the emergence antibiotic resistance, the use of silver as an antimicrobial has increased dramatically over the last few years (1) . Moreover, recent advances in nanotechnology have led to the creation of nano-sized silver particles which are now used in a diverse array of both medical and domestic products including catheters, sutures, disinfectants, furniture, paints, textiles, clothes and even telephones (2) . Indeed, in 2010 it was estimated that around 320 tons of AgNPs were manufactured globally (3) .
Nanoparticles are usually between 10 and 100 nm in diameter and, when compared with the parent material, they often exhibit new properties. Advantages include increased bioavailability due to improved solubility, longer biological half-life and increased catalytic activities as a result of the higher surface to volume ratio. Thus the main benefit is that a reduced concentration is needed to produce a desired response with less overall toxicity to normal cells (4) . The potential adverse effects of AgNp's on mammalian cells have been extensively studied both in vivo and in vitro although the data are conflicting and it is clear that more work is needed (5, 6) . This lack of clarity is due in part to a number of variables such as choice of methods for synthesis and purification, size difference, coatings and cell types tested.
Cytotoxicity of AgNPs has been tested in many cell types including those derived from cancers of the haemopoietc system (7). The effects are varied but include inhibition of the normal respiratory functions of the cells by targeting mitochondria and endoplasmic reticulum inducing oxidative stress and DNA damage (8) .
Although HERVs are expressed in both normal and diseased human tissues (9-12) they are often deregulated in cancers (reviewed (13) ) and have been implicated in inflammatory disorders such as multiple sclerosis (MS) (14) . Syncytin-1 is unusual for a HERV protein in that it performs an essential role in the morphogenesis of normal placenta by facilitating trophoblast cell fusion to form syncytiotrophoblasts and yet it has also been shown to promote the fusion of cancer cells (15, 16) . The increasingly wide range of products incorporating nanosilver particles has raised questions about their safety. Indeed their mode of action it is still poorly understood and the current study assesses the effects of AgNPs on leukaemic cell lines and explores the ability of these compounds induce expression of the HERV product syncytin-1.
Materials and methods

AgNP preparation
AGNp's of 7 nm and 50 nm sizes were prepared according to previously published work using AgNO 3 , sodium citrate and with NaBH 4 as the reducing agent (17) (18) (19) . Particle size and morphology were determined by TEM (CM30, Philips, Philips Analytical, Holland) at an accelerating voltage of 300 kV. The diameter of AgNP's (mean ± S.D.) was determined by measurement of more than 200 particles in random fields of view. The TEM size of the two AgNP preparations was 7.6 ± 1.2nm ("7nm" AgNPs) and 52.5 ± 17.9nm ("50nm" AgNPs).
Stock solutions (200vµg/ml) were prepared in sterile distilled water and stored at 4°C until required for cell culture experiments. Immediately prior to cell treatments they were diluted to the required concentrations using cell culture medium. h. Following this they were harvested for further study.
MTS proliferation assay
Cell viability was measured using CellTiter AQ96 reagent (Promega, Southhampton, UK)
according to the manufacturer's protocol. Briefly, cells were seeded in a 96-well plate at a seeding density of 5 x 10³ cells per well and incubated at 37°C with 5% CO 2 for 24 and 48 h. Trypan blue exclusion test Statistical analysis AQ96 assays and Trypan blue exclusion tests were all carried out in triplicate and the results were analysed using one way (ANOVA) with SPSS software. The data were presented as the mean value ± standard deviation (SD). To assess the level between treatments and respective controls, P values < 0.05 were considered statistically significant. All EC50 values were predicted using R version 3.2.2 drc package and Microsoft Excel 2010.
Results
Effect of AgNPs on cell growth and viability
The From the growth assays ( Figure 1 ) EC50s of 7nm AgNps on FA-AML1 cells were predicted to be 19 .6±4.9 μg/ml at 24h and 23±2.7 μg/ml 48h. EC50's of 50nm AgNp's on FA-AML-1 cells were predicted to be >65 and 55 ug/ml at 24h and 48h respectively. For MOLT-4 cells EC50's for both 7 nm and 50nm AgNPs were predicted to be > 50 μg/ml.
From the live/dead assays ( Figure 2 ) EC50s of 7nm AgNp's on FA-AML1 cells were predicted to be 17.9±2.9 μg/ml and >50 μg/ml for 50nm particles. EC50s for MOLT-4 cell death were >50µg/ml for both sizes of particles.
Effect of AgNPs on syncytin-1 mRNA expression RT-PCR was used to assess syncytin-1 expression in both FA-AML1 and MOLT-4 cells. The resulting gel images were quantitated and normalised to GAPDH using Image J software ( Figure 3 ). Syncytin-1 was induced in both cell types in response to treatment with both sizes of AgNPs albeit with different kinetics. In FA-AML1 cells the 7 nm particles induced syncytin-1 mRNA in a dose dependent manner up to 10µg/ml after which the levels dropped markedly ( Figure 3A) . Interestingly, although the mode of action is unknown, the 50 nm particle size showed a biphasic response with maximum induction of syncytin-1 transcript occurring at 5 µg/ml followed by a reduction in signal at 10 and 25 µg/ml with this increasing again at 50 µg/ml ( Figure 3B ). MOLT-4 cells showed an induction of syncytin-1 transcript at 5µg/ml of the 7 nm particles which remained constant for all higher concentrations of AgNPs ( Figure 3C ). When these cells were treated with the 50 nm sized particles, similar to FA-AML cells, a biphasic response was observed with maximum induction of syncytin-1 occurring at 10 ug/ml followed by a reduction at 25 and an increase at 50 µg/ml ( Figure 3D ).
Induction of syncytin-1 protein by AgNPs
The 
Discussion
By virtue of their unique physicochemical properties, nanoparticles cause effects that are related to their shape, size and chemical composition (20) (21) (22) (23) (24) . Silver nanoparticles are widely used in common consumer products including cosmetics, pesticides, detergents, face creams, toothpastes, medical products and even dietary supplements (25 What factors might explain this differential toxicity? One possibility is that this could be related to differences in the phagocytic activity of these cell types. Myeloid precursor cells can develop into macrophages which have high rates of phagocytosis that may simply result in higher uptake of AgNPs although how this relates to different particle size is unclear.
Another possibility is differential sensitivity of cells to oxidative stress (27, 28) since it has been shown that the production of reactive oxygen species (ROS) is the primary cause of cytotoxicity produced by different sizes of AgNPs particles (26, 29) . Moreover it has been shown that ROS production is more pronounced with smaller AgNPs which is also consistent with our results.
Irrespective of the differences in cytotoxicity displayed by the two sizes of AgNPs in FA-AML1 cells, of more concern was the ability of both particle sizes to induce expression of syncytin-1 mRNA and protein in both cell types tested. The reason for this is that syncytin-1 is known to be up-regulated in multiple sclerosis (30-32) and a variety of cancers (33, 34) , including lymphoma and leukaemia (35) . It is also known to promote the fusion of malignant cells, both to themselves and normal endothelial cells which contributes to enhanced genetic instability (15, 16, 34) and recent work has shown that mutations in the HERV-W genomic 3'-long terminal repeat induce up-regulation of syncytin-1 expression in urothelial cell carcinoma (36) .
In normal cells expression of syncytin-1 is mostly confined to the placenta (37) where it functions to promote both proliferation (38) and fusion of trophoblasts (39, 40) in order to form syncytio-trophoblasts. It is also know to suppress apoptosis in choriocarcinoma cells (41) and low levels of syncytin-1 have been linked to placental dysfunction in pre-eclampsia (42) (43) (44) . Most significantly expression of syncytin-1 has also been shown to suppress staurosporin-induced apoptosis in Chinese hamster ovary (CHO) cells (45) Although there is significant evidence for syncytin-1 conferring a growth/survival advantage in malignant cells, there is also evidence that its expression induces demyelination and cell death in oligodendrocytes which is consistent with the protein playing a causative role in neurodegenerative disease (48) . Indeed, as previously mentioned, syncytin-1 is thought to play an instrumental role in MS (30, 32, 49) . Thus it is significant that AgNPs are also known to cause neuronal damage (50,51) and we speculate this could be augmented by induction of syncytin-1.
In conclusion, the widespread use of AgNPs in many products means that humans will invariably be exposed to these agents and, although speculative, our results support the conclusions of others that this may not be without risk (for review see (52)). AgNPs are known to promote ROS production and DNA damage (26, 53, 54) which is consistent with their potential use as cancer therapeutics (29, 55, 56) . However, as with most cytotoxic drugs, FA-AML1 and MOLT-4 cells were treated with 7 and 50 nm AgNPs at 5, 10, 25 and 50 µg/ml for 24 h. GAPDH was used as an internal control. Densitometric analysis was performed using Image J software and the signals normalised to GAPDH (A) FA-AML1 cells
